Twist Bioscience Corporation TWST
149.97 USD -2.81 -1.84%
As of Nov 2, 9:41 AM ET
25.45 52-week range 205.00
- YTD
- +372.79%
- 1 year
- +355.97%
- Open
- 153.17
- Prev close
- 152.78
- Mkt cap
- 9.99B
- Vol
- 88.35K
- Avg vol
- 2.33M
- EPS
- -2.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 149.30
- High
- 154.11
- Forward P/E
- -381.95
- Beta
- 2.19
- Short ratio
- 3.22
- Inst. own
- 116.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 152.78
- 200-d avg
- 88.45
- 1y target
- 168.25
MAX chart
Chart tools
Chart is warming up
The all-time price history for TWST has not been loaded yet. Try again in a moment.
Altman Z-Score
23.99 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
P/E -21.6×
P/S 4.5×
P/B 3.6×
P/FCF -22.3×
EV/EBITDA -31.4×
EV/Sales 4.3×
FCF Yield -4.5%
Gross Margin 50.7%
Operating Margin -36.2%
Net Margin -20.6%
ROE -16.4%
ROIC -24.1%
ROA -12.1%
Revenue 20.3%
Operating Income 38.3%
EPS (diluted) 63.9%
Free Cash Flow -9.3%
Current Ratio 3.6×
Quick Ratio 3.3×
Debt / Equity 0.3×
Net Debt / EBITDA 0.9×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-09-30